Research Paper Volume 16, Issue 7 pp 6163—6187

KIF3C: an emerging biomarker with prognostic and immune implications across pan-cancer types and its experiment validation in gastric cancer


Figure 9. Validation of KIF3C expression. (A) qRT-PCR analysis of KIF3C mRNA in the GC cell lines and normal gastric cell line. KIF3C mRNA levels in GC tissues and normal tissues in (B) GSE26899, (C) GSE29998, (D) GSE27342, (E) GSE54129, (F) GSE118916. *p < 0.05, **p < 0.01, ***p < 0.001.